期刊
MOLECULAR ONCOLOGY
卷 15, 期 7, 页码 1942-1955出版社
WILEY
DOI: 10.1002/1878-0261.12923
关键词
ChIP‐ seq; cistrome; epigenomics; metastasis; prostate cancer; transcriptomics
类别
The study investigated the epigenomic landscape of prostate cancer drivers in four clonal metastatic tumors from a single patient, revealing a core transcriptional program in clonal metastatic prostate cancer despite differences in the AR cistrome. Shared AR binding sites among healthy prostate, primary prostate cancer, and metastatic tumors signify core AR-driven transcriptional regulation within the prostate cell lineage.
The epigenomic regulation of transcriptional programs in metastatic prostate cancer is poorly understood. We studied the epigenomic landscape of prostate cancer drivers using transcriptional profiling and ChIP-seq in four clonal metastatic tumors derived from a single prostate cancer patient. Our epigenomic analyses focused on androgen receptor (AR), which is a key oncogenic driver in prostate cancer, the AR pioneer factor FOXA1, chromatin insulator CCCTC-Binding Factor, as well as for modified histones H3K27ac and H3K27me3. The vast majority of AR binding sites were shared among healthy prostate, primary prostate cancer, and metastatic tumor samples, signifying core AR-driven transcriptional regulation within the prostate cell lineage. Genes associated with core AR-binding events were significantly enriched for essential genes in prostate cancer cell proliferation. Remarkably, the metastasis-specific active AR binding sites showed no differential transcriptional output, indicating a robust transcriptional program across metastatic samples. Combined, our data reveal a core transcriptional program in clonal metastatic prostate cancer, despite epigenomic differences in the AR cistrome.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据